ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 1171

$632K Total Retail Price of All Prescriptions

Rank: 127 out of 1171

525 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 546 474 1 2
LISINOPRIL 474 419 2 3
HYDROCHLOROTHIAZIDE 440 374 3 9
SIMVASTATIN 419 385 4 1
FUROSEMIDE 410 373 5 6
WARFARIN SODIUM 373 363 6 12
LEVOTHYROXINE SODIUM 340 334 7 4
METFORMIN HCL 282 237 8 7
DONEPEZIL HCL 276 276 9 24
ATENOLOL 212 179 10 15
ATORVASTATIN CALCIUM 201 186 11 10
NAMENDA 200 200 12 42
METOPROLOL TARTRATE 200 169 12 11
LOSARTAN POTASSIUM 190 141 14 14
TRAMADOL HCL 183 170 15 18
OMEPRAZOLE 177 160 16 5
CARVEDILOL 143 121 17 20
HYDROCODONE-ACETAMINOPHEN 139 112 S3 18 8
PRAVASTATIN SODIUM 138 128 19 13
SERTRALINE HCL 128 111 20 23
METOPROLOL SUCCINATE 112 112 21 17
POTASSIUM CHLORIDE 106 105 22 19
MELOXICAM 106 102 22 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 96 24 26
FLUTICASONE PROPIONATE 104 96 24 30
ESCITALOPRAM OXALATE 103 103 26 69
DIOVAN 100 93 27 32
GABAPENTIN 97 79 28 16
ALLOPURINOL 96 82 29 31
TAMSULOSIN HCL 95 81 30 28
CLONIDINE HCL 93 72 31 45
QUETIAPINE FUMARATE 89 83 32 54
BUSPIRONE HCL 89 82 32 129
MIRTAZAPINE 84 76 34 50
HYDRALAZINE HCL 82 70 35 60
CLOPIDOGREL 79 79 36 35
TRAZODONE HCL 78 71 37 37
AGGRENOX 71 71 38 148
JANUVIA 70 52 39 66
CIPROFLOXACIN HCL 67 62 40 61
ACTOS 65 58 41 123
LEVEMIR FLEXPEN 65 65 41 145
DILTIAZEM 24HR CD 65 65 41 101
GLIPIZIDE ER 63 50 44 86
GLIPIZIDE 62 49 45 47
KLOR-CON M20 62 59 45 41
DIGOXIN 62 62 45 68
DICLOFENAC SODIUM 59 48 48 103
RANITIDINE HCL 58 57 49 38
CELEBREX 56 55 50 100
PLAVIX 52 52 51 55
ZOLPIDEM TARTRATE 52 34 51 21
CITALOPRAM HBR 52 47 51 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.